L.B. Bohle Innovativ 02/2017 EN
The customer magazine of the special maschine builder L.B. Bohle from Ennigerloh/Germany is published twice a year.
The customer magazine of the special maschine builder L.B. Bohle from Ennigerloh/Germany is published twice a year.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The two CEO’s Tim Remmert (r.) and<br />
Thorsten Wesselmann (l.) in front of<br />
the KOCO ® at the Technology Center.<br />
portance as a growing driver almost completely due to the economic<br />
and government crisis.<br />
L.B. <strong>Bohle</strong> has been pushing continuous production forward<br />
for years: How far has the development advanced? When will<br />
the market be ready for the first plant?<br />
Wesselmann: There is a great deal of interest in continuous production.<br />
For experts worldwide, its is no longer a question of “if”, but rather<br />
“when” the breakthrough will come. It is the same as with e-mobility.<br />
But everybody in the industry knows: The “point of no return” has already<br />
been passed. At the same time, we have to be aware that we will need<br />
perseverance because new long-term production plants are planned.<br />
How can you facilitate the breakthrough of the new procedures?<br />
Wesselmann: At the Technology Center, we make first -class development<br />
and testing facilities available to customers and scientists. Moreover, we<br />
are actively advancing the topic with international conferences – e.g.<br />
from 19 – 21 September <strong>2017</strong> in Ennigerloh.<br />
What potential does continuous production offer?<br />
Wesselmann: For pharmaceutical manufacturers, it leads to shorter time<br />
to market, more flexible production including small batches and highest<br />
precision and quality due to comprehensive process monitoring and<br />
control. All in all, the pharmaceutical industry can save time and money.<br />
Remmert: For machine builders like us, the technology still offers<br />
considerable growth potential: A complete continuous production<br />
plant quickly reaches an investment volume of EUR six to 20 million<br />
(depending on the operating parameters) and the first steps will<br />
certainly be partial solutions.<br />
INNOVATIV 2 | <strong>2017</strong> 7